Skip to content

Group Metacognitive Therapy vs. Mindfulness Meditation Therapy in a Transdiagnostic Patient Sample: A Randomised Feasibility Trial.

Lora Capobianco, David Reeves, Anthony P Morrison, Adrian Wells

Psychiatry Research January 2018 DOI: 10.1016/j.psychres.2017.11.045 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Feasibility randomized controlled trial Peer reviewed
Sample size 40
Population Adults aged 19-56 with anxiety and depression
Interventions Metacognitive Therapy (MCT) Mindfulness Based Stress Reduction (MBSR)
Duration Eight weeks of treatment, with 6-month follow-up
Measures Hospital Anxiety and Depression Scale (HADS) total score
Topics Meditation
Keywords Feasibility Metacognitive therapy
Key findings Preliminary analyses suggested group Metacognitive Therapy was more effective than group Mindfulness Based Stress Reduction in reducing anxiety and depression and in reducing positive and negative metacognitive beliefs, with reliable improvement rates favoring MCT at post-treatment and six-month follow-up. Both treatments appeared feasible and acceptable, but the authors state a larger, definitive trial is required.

Abstract

Two transdiagnostic therapies for treating psychological disorder are Metacognitive Therapy (MCT) and Mindfulness Based Stress Reduction (MBSR). These two approaches have yet to be compared and therefore the current study aimed to evaluate the feasibility of a study of group MCT and MBSR in treating anxiety and depression. A feasibility trial with 40 participants (aged 19-56) was conducted. Patients were randomly assigned to receive either eight weeks of group MCT or MBSR. The primary outcome was feasibility which included recruitment rates, retention and treatment acceptability. The primary symptom outcome was the Hospital Anxiety and Depression Scale (HADS) total score, which provided an overall measure of distress. Both treatments were found to be acceptable with low attrition and similar ratings of acceptability. Changes in outcomes were analyzed based on the intention-to-treat principle using mixed effect models. Preliminary analyses revealed that MCT was more effective in treating anxiety and depression in comparison to MBSR, and in reducing both positive and negative metacognitive beliefs. Reliable improvement rates favoured MCT at post-treatment and 6-month follow up. Both treatments appeared to be feasible and acceptable in treating transdiagnostic samples; however, a larger, definitive trial is required. The limitations and directions for future research are discussed.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Cited by 5

Cites 8

and 3 more in the library

Explore topics